ea0081ep1021 | Thyroid | ECE2022
Fernandez Valero Andrea
, Damas-Fuentes Miguel
, Montoro Jose Ignacio Marti nez
, Vega Maria Molina
, Doblas Isabel Mancha
, Garcia Aleman Jorge
, Ochoa Arantzazu Sebastian
, Manuel Trigo Perez Jose
, Jose Tinahones Madueno Francisco
Introduction: Differentiated thyroid cancer (DTC) represent 85- 90 % of all thyroid cancer cases. Most of these have an excellent prognosis with standard treatment. However, between 7 and 23% will develop distant metastases and, of these, more than 65% will become radioactive iodine-refractory. In some of these patients who are considered to be radioiodine-refractory with rapidly progressive or symptomatic disease, or in patients who are not candidates for other therapies, the...